middle.news
Genetic Signatures Narrows FY2026 Loss 30% with Danish Contract and Cost Cuts
9:09am on Tuesday 25th of August, 2026 AEST
•
Healthcare
Read Story
Genetic Signatures Narrows FY2026 Loss 30% with Danish Contract and Cost Cuts
9:09am on Tuesday 25th of August, 2026 AEST
Key Points
FY2026 loss narrowed 30% to $14 million
Revenue down 7% to $14.8 million amid market pressures
Completed organisational restructure with $5 million annual savings
Signed decade-long supply agreement with Hvidovre Hospital, Denmark
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Genetic Signatures (ASX:GSS)
OPEN ARTICLE